Panbela Therapeutics, Inc. ( PBLA) - Key Metrics
PBLA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0 | -$1.48 | -$0.44 | -$0.44 |
| 2024Q2 | $0 | -$1.47 | -$0.20 | -$0.20 |
| 2024Q1 | $0 | -$2.28 | -$3 | -$3 |
| 2023Q4 | $0 | -$2.07 | -$0.99 | -$0.99 |
| 2023Q3 | $0 | -$53.74 | -$45.82 | -$45.82 |
PBLA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | 0% | -0.06 |
| 2024Q2 | 0% | -0.06 |
| 2024Q1 | 0% | -0.06 |
| 2023Q4 | 0% | -167.58 |
| 2023Q3 | 0% | -0.12 |
PBLA
Price: $0
52 week price:
Earnings Per Share: -34.51 USD
P/E Ratio: -0.01
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.4 million
Market Capitalization: 485